ScreenerHero

ATB Antibiotice S.A.

BVB · RO · Healthcare · Drug Manufacturers - Specialty & Generic · antibiotice.ro
1.998RON+0.91%Mkt Cap: 293.05M $P/E: 199.80

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap293.05M USD
Enterprise Value366.97M USD
Revenue (TTM)134.71M USD
Gross Profit92.39M USD
Net Income (TTM)11.31M USD
Revenue/Share0.92 RON
Last Price1.998 RON
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.4K
CountryRO
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINROATBIACNOR9
Valuation
P/E (Trailing)199.80
P/E (Forward)—
PEG3.89
EV/EBITDA20.15
EV/Revenue2.72
P/S2.16
P/B1.43
EPS (TTM)0.01
EPS (Forward)—
52W Range
1.75228% of range2.640
52W High2.640 RON
52W Low1.752 RON
Profitability
Gross Margin65.53%
Oper. Margin10.35%
EBITDA Margin13.52%
Profit Margin8.02%
ROE5.55%
ROA3.72%
Growth
Revenue Growth-4.70%
Earnings Growth-88.90%
Cash Flow & Leverage
Operating CF15.83M USD
CapEx (TTM)31.16M USD
FCF Margin-12.07%
FCF Yield-5.55%
Net Debt76.56M USD
Net Debt/EBITDA4.20
Balance Sheet
Debt/Equity0.25
Current Ratio1.25
Quick Ratio0.79
Book Value/Sh1.39 RON
Cash/Share0.0050 RON
Dividends
Fwd Div Rate0.04 RON
Trail. Div Rate0.04 RON
Div. Yield1.80%
5Y Avg Yield0.67%
Payout Ratio169.89%
Ex-Div DateOct 15, 2026
Pay Date—
Splits
Last Split1.18192:1
Split DateJul 11, 2013
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.671.34M
Float227.94M
Insiders58.05%
Institutions13.63%
Technical
SMA 502.020 (-1.1%)
SMA 2002.089 (-4.4%)
Beta0.21
S&P 52W Chg16.45%
Avg Vol (30d)93.72K
Avg Vol (10d)70.60K
Technical Indicators
RSI (14)56.7
MACD-0.0111
MACD Signal-0.0324
MACD Hist.+0.0213
BB Upper2.025 RON
BB Middle1.917 RON
BB Lower1.809 RON
BB Width11.29%
ATR (14)0.0540 RON
Vol Ratio (20d)0.89x